As shown in Figure 7B(left panel) RAMB1 treatment causes very rapid (top) and dose-dependent (bottom) decrease of cyclin D1 levels suggesting failure of cervical cancer to enter the S-phase of the cell cycle may contribute to the loss of cell viability [41]. Here, CCND1 is linked to cervical carcinoma.